Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Capecitabine Plus Gemcitabine For Metastatic Renal Cell Carcinoma

NCT00042965 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00042965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00042965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Capecitabine Plus Gemcitabine For Metastatic Renal Cell Carcinoma
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2002
Completion date
September 30, 2006
Enrollment
60 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer